For clinical researchers shaping a Phase II study, compare single-arm and randomized designs, choose an endpoint that fits the treatment and disease, and estimate sample size from your assumptions. Set out the primary analysis, safety monitoring, and go/no-go criteria. Leave with a protocol outline and statistical planning notes to take to your study team.
Phase II Trials
Plan a Phase II trial with an efficacy endpoint, sample size, and analysis approach.
Use Phase II Trials
$49.99 / month
Includes every Agent on Ai-GEN. 15,000+ Agents for one monthly price, cancel anytime.
From the creator of GPTs with 8.5M+ chats · 4.2 stars · 37K+ reviews
Start Phase II Trials — $49.99 / month
Your account is created at checkout. After payment, this Agent opens when access is ready.
Already subscribed? Sign in · Account terms
Cancel future renewals from Account & Billing → Subscriptions.
What it writes
- Phase II protocol outline
- Sample size assumptions and estimate
- Statistical analysis and go/no-go plan
How to use it
Include the disease, treatment, proposed endpoint, control group, and expected effect size in your first message. Add your enrollment limit and study duration so sample size and design suggestions fit your constraints.
What you bring
- Disease area and treatment under study
- Proposed endpoint and study duration
- Enrollment target and design constraints
- A defined research question
- A candidate treatment or intervention
A good fit for
- Choosing a Phase II design for an oncology drug with limited prior data
- Estimating enrollment for a randomized trial with a binary response endpoint
- Setting go/no-go rules for an early study in a rare disease
Ways to start
A few requests this Agent can handle.
I’m planning a Phase II oncology trial for a new oral drug. What single-arm design and response endpoint could fit, and what assumptions do I need for a sample size estimate?
We want to randomize 90 patients with moderate asthma, 2:1 to treatment or control, using change in FEV1 at 12 weeks. What analysis approach and design issues should we consider?
Our rare-disease study can enroll about 35 people over two years. Suggest a Phase II endpoint, safety monitoring plan, and go/no-go criteria for a treatment with uncertain efficacy.
Good to know
This workspace provides text assistance.
- Choosing treatment for an individual patient
- Replacing biostatistician, ethics, or regulatory review
- Cannot verify current trial regulations or guidance
- Cannot inspect files or analyze patient-level datasets
Before you subscribe
What am I buying?
One monthly subscription that opens this Agent and every other Agent on Ai-GEN. Cancel from Account & Billing.
What happens after payment?
Checkout creates or uses your Ai-GEN account. When payment and entitlement are confirmed, the purchased Agent opens. Choose a starter task, add your inputs, and send your first request.
Can I cancel?
Yes. Manage cancellation under Account & Billing → Subscriptions. Review the status and cancellation details shown there before confirming.
Can I use the response in my work?
Use it as a draft to review and adapt. Verify calculations, facts, rights, and suitability before relying on it. Do not provide information you do not have permission to share.
Report This Agent
Tell Ai-GEN about broken behavior, poor performance, misleading capabilities, or a safety concern.